AmCad BioMed
私たちについて
AmCad BioMed Corporation is dedicated to developing innovative Computer-Assisted Detection (CAD). Our patented algorithms provide medical professionals detailed quantification and visualization of sonographic characteristics, bolstering clinicians’ expertise with AI-driven technology. AmCad BioMed has successfully developed and commercialized a series of the pioneering, first-in-the-world medical devices allow for more confident decision making and less subject diagnosis. Our clinically proven and FDA/CE certificated pipeline includes AmCAD-UT for thyroid nodules analysis and AmCAD-UO for obstructive sleep apnea detection.AmCad BioMed Corporation is dedicated to developing innovative Computer-Assisted Detection (CAD). Our patented algorithms provide medical professionals detailed quantification and visualization of sonographic characteristics, bolstering clinicians’ expertise with AI-driven technology. AmCad BioMed has successfully developed and commercialized a series of the pioneering, first-in-the-world medical devices allow for more confident decision making and less subject diagnosis. Our clinically proven and FDA/CE certificated pipeline includes AmCAD-UT for thyroid nodules analysis and AmCAD-UO for obstructive sleep apnea detection.
私たちの価値観
We believe in a future where AI empowers physicians to make rapid and precise diagnoses, thus enabling more efficient use of medical resources. We continue to pour R&D and clinical validation resources into pioneering ultrasound AI to conquer unmet medical needs in the fields of thyroid cancer detection, Obstructive Sleep Apnea detection, real time analysis for fatty liver and liver fibrosis, and ultrasound guided intervention for MSK therapy. With the right combination of medical expertise and AI-ingenuity, we are pioneering better healthcare for all.